Pomdoctor Limited, operating through its various divisions, runs an e-commerce platform for the direct sale of pharmaceutical products to consumers. The company ...
Pomdoctor Limited (POM) is a digital healthcare company headquartered in Guangzhou, China, with an operating focus on chronic disease care. The company runs an online medical services platform that is designed to support long-term illness management, combining remote care enablement with pharmaceutical provisioning. In practice, Pomdoctor’s model is oriented around ...Pomdoctor Limited (POM) is a digital healthcare company headquartered in Guangzhou, China, with an operating focus on chronic disease care. The company runs an online medical services platform that is designed to support long-term illness management, combining remote care enablement with pharmaceutical provisioning. In practice, Pomdoctor’s model is oriented around coordinating patients with healthcare professionals while also facilitating access to essential medications through an integrated supply chain.
From a business perspective, the company operates within the “Medical – Pharmaceuticals” and broader healthcare/health-information ecosystem. Its core offering is the platform layer—essentially a virtual hospital and chronic-disease services interface—aimed at improving continuity of care for patients who require ongoing monitoring and treatment. The platform approach also supports recurring or ongoing engagement typical of chronic disease workflows, where care planning, follow-ups, and medication access are tightly linked.
On the products and services side, Pomdoctor’s activities encompass (1) online healthcare services for chronic diseases and (2) pharmaceutical-related services that function like an e-commerce and fulfillment mechanism. Through its system, it connects individual users with medical experts and relevant medication supply stakeholders such as pharmacies and distributors. This integration reduces friction in the patient journey by aligning clinical guidance with medication procurement.
Regarding operations, metrics provided in the source snapshot indicate active trading on NASDAQ (following its 2025 IPO) and reveal a growth-oriented posture with ongoing investment requirements. Financially, the snapshot metrics show negative margins on an operating/earnings basis (TTM), along with low liquidity ratios (e.g., current ratio below 1) and negative free cash flow measures, which is consistent with early-stage scaling, platform development, and working-capital intensity that can occur in internet-enabled healthcare and pharmaceutical service models.
In terms of cost structure and BOM-style considerations (where applicable), typical cost drivers for a platform that combines digital services with pharmaceutical supply include technology/product development (platform and services), customer acquisition and marketing, clinical/medical services enablement, and inventory/pharmacy fulfillment costs for medications. While exact segment cost breakdowns are not provided, the integrated “services + medication supply chain” approach implies that both operating expenses and supply-related working capital can materially affect cash conversion.
Key people include Zhenyang Shi (co-founder, Chairman, and CEO). The company’s strategic direction (as described in the overview snippets) emphasizes building infrastructure for predictive healthcare data and chronic disease management capabilities, which suggests continued investment in analytics, care coordination workflows, and platform expansion to support long-term disease outcomes.
Overall, Pomdoctor (POM) positions itself as a chronic-disease-focused virtual healthcare infrastructure provider in China, seeking to combine online medical services with pharmaceutical access to create a more connected and continuous care experience for patients.
YoYYoY means Year-over-Year. It compares the latest annual value with the previous annual value to show long-term trend strength.
QoQQoQ means Quarter-over-Quarter. It compares the latest quarter with the immediately previous quarter to show short-term momentum changes.
RevenueThe total money that came through the front door from selling things, before paying a single bill. Think of it as the grand total of every credit card swipe from customers. (YoY compares this year to last year's performance, while QoQ compares the current three months to the previous three).
$399.9M
+16.7%
—
Net IncomeThe absolute bottom line. If the company paid every single supplier, employee, banker, and tax collector, this is the actual money left in their pocket at the end of the day.
$-212.6M
-48.3%
—
Gross MarginThe basic markup. If they sell a $100 pair of sneakers, this percentage tells you how much of that price tag is profit right after paying for the rubber and shoelaces, but before paying for things like store rent or TV commercials.
+13.1%
-6.1%
—
Operating MarginThe 'day job' efficiency score. Out of every dollar a customer spends, this shows how many cents the company keeps after making the product AND paying for all the everyday corporate overhead (like salaries, marketing, and keeping the lights on).
-29.1%
-286.5%
—
Net MarginThe final take-home percentage. When you strip away every conceivable cost, tax, and interest payment, this is the exact number of cents the company truly gets to keep from every dollar in sales.
-53.2%
-27.0%
—
Free Cash FlowThe holy grail of corporate cash. It's the spendable, physical money left over after the business pays for its daily operations AND buys the big, expensive upgrades (like new factories or servers) it needs to survive. This is the 'free' money they can use to pay dividends or buy back stock.
$-149.5M
-824.6%
—
FCF MarginThe ultimate cash conversion rate. It shows how good the company is at turning regular sales directly into cold, hard, spendable cash. A high percentage means the business is an absolute cash-printing machine.
-37.4%
-691.9%
—
Debt / EquityThe financial risk gauge. It compares how much of the company's empire was built using borrowed money (loans) versus the owners' own money (shareholders). A high number means they are heavily leveraged and playing a riskier game; a low number means they are playing it safe.
-100.2%
-414.2%
-414.2%
Current RatioThe 12-month survival check. It simply compares the cash they have right now (plus things they can quickly turn into cash) against the immediate bills they absolutely must pay this year. A score above 1 means they have enough in the wallet to cover the upcoming bills without panicking.
0.48x
+129.9%
+129.9%
Total AssetsThe absolute size of the company's empire. It bundles together absolutely everything of value they own—from the cash in the register and the inventory in the warehouse, to the software patents in the vault and the factories on the ground.
